Problem statement: Answer the multiple choice question.
Query: Which compound exhibits a -4.504% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a. COc1ccc(CC(=O)OCC(=O)Nc2ccc3c(c2)OCO3)cc1
b. Cc1cccc(-c2noc(CCC(=O)Nc3ccccc3)n2)c1
c. Cc1ccc(SCC(=O)NC2CC3CCC(C2)N3C)cc1
d. Clc1ccc(CSc2ccc(-c3cccnc3)nn2)cc1
Answer: b. Cc1cccc(-c2noc(CCC(=O)Nc3ccccc3)n2)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cccc(-c2noc(CCC(=O)Nc3ccccc3)n2)c1
Cc1cccc(-c2noc(CCC(=O)Nc3ccccc3)n2)c1
3-[3-(3-methylphenyl)-1,2,4-oxadiazol-5-yl]-N-phenylpropanamide